Mark Alan Matson MD

Nephrology•Saint Paul, MN

Physician

Join to View Full Profile

1000 Westgate DriveSuite 149Saint Paul, MN 55114
Phone+1 651-641-2924
Fax+1 651-641-2901

Education & Training

Hennepin HealthcareFellowship, Nephrology, 1989 - 1991
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1986 - 1989
University of Minnesota Medical SchoolClass of 1986

Certifications & Licensure

MN State Medical License 2007 - 2025
WA State Medical License 2003 - 2008
IA State Medical License 1991 - 2006
ID State Medical License 2003 - 2005
WI State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Start of enrollment: 2010 Sep 01
Completed
Phase 1
Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus Start of enrollment: 2010 Nov 01
Completed
Phase 1, Phase 2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension Start of enrollment: 2012 Jan 01
Completed
Phase 1
Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers Start of enrollment: 2013 Jul 01
Unknown status
Phase 1
Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine Start of enrollment: 2013 Nov 01
Completed
Phase 1
Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects Start of enrollment: 2013 Apr 01
Completed
Phase 2, Phase 3
A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers Start of enrollment: 2014 Mar 01
Completed
Phase 1
A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers Start of enrollment: 2014 May 01
Completed
Phase 1
A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products Start of enrollment: 2015 Sep 01
Completed
Not Applicable
Implant Pharmacokinetic and Pharmacodynamic Study Start of enrollment: 2009 Sep 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

12 citations
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.
Nandita Bose, Nadine R. Ottoson, Xiaohong Qiu, Ben Harrison, Jamie Lowe
Journal of Immunology. 2019-05-15
4 citations
Immune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labial...
Hugh McTavish, Katherine W. Zerebiec, Jay C. Zeller, Laurie L. Shekels, Mark A. Matson
Immunity, Inflammation and Disease. 2019-03-01
35 citations
Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients
Marc L. Reitman, Victor Dishy, Allison Moreau, William S. Denney, Chengcheng Liu
Journal of Clinical Pharmacology. 2012-09-01

Press Mentions

Injection Lowers Cholesterol in Preliminary Human TrialNovember 30th, 2011

Mark Alan Matson MD

Dr. Matson is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.